Interferon restores replication fork stability and cell viability in BRCA-defective cells via ISG15.

Autor: Moro RN; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Biswas U; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Kharat SS; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, 21702, MD, USA., Duzanic FD; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Das P; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015GD, Rotterdam, the Netherlands., Stavrou M; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Raso MC; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland., Freire R; Fundación Canaria del Instituto de Investigación Sanitaria de Canarias (FIISC), Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, 38200, La Laguna, Spain.; Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain., Chaudhuri AR; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015GD, Rotterdam, the Netherlands., Sharan SK; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, 21702, MD, USA., Penengo L; University of Zurich, Institute of Molecular Cancer Research, 8057, Zurich, Switzerland. penengo@imcr.uzh.ch.

Publikováno v: Nature communications [Nat Commun] 2023 Oct 02; Vol. 14 (1), pp. 6140. Date of Electronic Publication: 2023 Oct 02.